12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 06/06 12:07
Gainers
- Bluejay Diagnostics (NASDAQ:BJDX) stock rose 55.3% to $2.36 during Friday's pre-market session. The market value of their outstanding shares is at $3.5 million.
- Venus Concept (NASDAQ:VERO) shares increased by 50.62% to $3.6. The company's market cap stands at $5.1 million.
- Eyenovia (NASDAQ:EYEN) stock rose 39.79% to $4.39. The market value of their outstanding shares is at $12.6 million.
- Regencell Bioscience (NASDAQ:RGC) stock moved upwards by 23.2% to $770.0. The company's market cap stands at $10.0 billion.
- Helius Medical Tech (NASDAQ:HSDT) stock moved upwards by 17.54% to $1.34.
- Akanda (NASDAQ:AKAN) stock moved upwards by 14.12% to $1.45. The market value of their outstanding shares is at $3.2 million.
Losers
- Vera Therapeutics (NASDAQ:VERA) stock decreased by 29.8% to $21.5 during Friday's pre-market session. The market value of their outstanding shares is at $1.3 billion.
- Accuray (NASDAQ:ARAY) shares declined by 22.37% to $1.18. The company's market cap stands at $121.5 million.
- Liminatus Pharma (NASDAQ:LIMN) shares fell 17.12% to $20.39. The company's market cap stands at $530.4 million.
- Scinai Immunotherapeutics (NASDAQ:SCNI) shares declined by 13.24% to $2.82. The company's market cap stands at $2.6 million.
- Durect (NASDAQ:DRRX) shares fell 11.01% to $0.48. The market value of their outstanding shares is at $14.8 million.
- NewGenIvf Group (NASDAQ:NIVF) shares fell 10.44% to $2.06. The company's market cap stands at $1.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.